| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Advaxis Inc (NASDAQ: ADXS)
ADXS Technical Analysis
5
| As on 9th Jun 2023 ADXS STOCK Price closed @ 1.15 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 0.47 & Strong Buy for SHORT-TERM with Stoploss of 0.64 we also expect STOCK to react on Following IMPORTANT LEVELS. |
ADXSSTOCK Price
| Open | 1.25 | Change | Price | % |
| High | 1.25 | 1 Day | 0.05 | 4.55 |
| Low | 1.10 | 1 Week | 0.30 | 35.29 |
| Close | 1.15 | 1 Month | -2.40 | -67.61 |
| Volume | 3727 | 1 Year | 0.27 | 30.68 |
| 52 Week High 4.96 | 52 Week Low 0.06 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| ADXS Daily Charts |
ADXS Intraday Charts |
Whats New @ Bazaartrend |
ADXS Free Analysis |
|
|
ADXS Important Levels Intraday
| RESISTANCE | 1.44 |
| RESISTANCE | 1.35 |
| RESISTANCE | 1.29 |
| RESISTANCE | 1.23 |
| SUPPORT | 1.07 |
| SUPPORT | 1.01 |
| SUPPORT | 0.95 |
| SUPPORT | 0.86 |
ADXS Forecast May 2024
| 4th UP Forecast | 2.02 |
| 3rd UP Forecast | 1.74 |
| 2nd UP Forecast | 1.57 |
| 1st UP Forecast | 1.4 |
| 1st DOWN Forecast | 0.9 |
| 2nd DOWN Forecast | 0.73 |
| 3rd DOWN Forecast | 0.56 |
| 4th DOWN Forecast | 0.28 |
ADXS Weekly Forecast
| 4th UP Forecast | 1.84 |
| 3rd UP Forecast | 1.62 |
| 2nd UP Forecast | 1.48 |
| 1st UP Forecast | 1.35 |
| 1st DOWN Forecast | 0.95 |
| 2nd DOWN Forecast | 0.82 |
| 3rd DOWN Forecast | 0.68 |
| 4th DOWN Forecast | 0.46 |
ADXS Forecast2024
| 4th UP Forecast | 10.59 |
| 3rd UP Forecast | 7.56 |
| 2nd UP Forecast | 5.69 |
| 1st UP Forecast | 3.82 |
| 1st DOWN Forecast | -1.52 |
| 2nd DOWN Forecast | -3.39 |
| 3rd DOWN Forecast | -5.26 |
| 4th DOWN Forecast | -8.29 |
Advaxis Inc ( NASDAQ USA Symbol : ADXS )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
ADXS Business Profile
Advaxis, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of proprietary Listeria monocytogenes (Lm) technology antigen delivery products in the United States. The company is developing ADXS-PSA, which is in Phase 2 clinical trials for the treatment of metastatic prostate cancer; ADXS-503 that is in Phase 1/2 clinical trials for the treatment of non-small cell lung cancer; and ADXS-504 for the treatment of prostate cancer. It is also conducting clinical studies of Lm Technology immunotherapies in the following areas of disease focused hotspot/off-the-shelf neoantigen-directed therapies; human papilloma virus-associated cancers; and prostate cancer. The company has collaborations and partnerships with Merck & Co., Inc.; OS Therapies, LLC; Aratana Therapeutics Inc.; Biocon Limited; Global BioPharma Inc.; Knight Therapeutics Inc; and others. Advaxis, Inc. was founded in 2002 and is based in Monmouth Junction, New Jersey. Address: 9 Deer Park Drive, Monmouth Junction, NJ, United States, 08852
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service